Monetary conversion factors for economic evaluations of substance use disorders

Kathryn McCollister, Xuan Yang, Bisma Sayed, Michael French, Jared A. Leff, Bruce R. Schackman

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Aims Estimating the economic consequences of substance use disorders (SUDs) is important for evaluating existing programs and new interventions. Policy makers in particular must weigh program effectiveness with scalability and sustainability considerations in deciding which programs to fund with limited resources. This study provides a comprehensive list of monetary conversion factors for a broad range of consequences, services, and outcomes, which can be used in economic evaluations of SUD interventions (primarily in the United States), including common co-occurring conditions such as HCV and HIV. Methods Economic measures were selected from standardized clinical assessment instruments that are used in randomized clinical trials and other research studies (e.g., quasi-experimental community-based projects) to evaluate the impact of SUD interventions. National datasets were also reviewed for additional SUD-related consequences, services, and outcomes. Monetary conversion factors were identified through a comprehensive literature review of published articles as well as targeted searches of other sources such as government reports. Results Eight service/consequence/outcome domains were identified containing more than sixty monetizable measures of medical and behavioral health services, laboratory services, SUD treatment, social services, productivity outcomes, disability outcomes, criminal activity and criminal justice services, and infectious diseases consequences. Unit-specific monetary conversion factors are reported, along with upper and lower bound estimates, whenever possible. Conclusions Having an updated and standardized source of monetary conversion factors will facilitate and improve future economic evaluations of interventions targeting SUDs and other risky behaviors. This exercise should be repeated periodically as new sources of data become available to maintain the timeliness, comprehensiveness, and quality of these estimates.

Original languageEnglish (US)
Pages (from-to)25-34
Number of pages10
JournalJournal of Substance Abuse Treatment
Volume81
DOIs
StatePublished - Oct 1 2017

Fingerprint

Substance-Related Disorders
Cost-Benefit Analysis
Economics
Criminal Law
Information Storage and Retrieval
Program Evaluation
Financial Management
Administrative Personnel
Social Work
Health Services
Communicable Diseases
Randomized Controlled Trials
HIV
Exercise
Research

Keywords

  • Cost-benefit analysis
  • Cost-effectiveness analysis
  • Economic consequences
  • Economic evaluation
  • Monetary conversion factors
  • Substance use disorders

ASJC Scopus subject areas

  • Phychiatric Mental Health
  • Medicine (miscellaneous)
  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

Monetary conversion factors for economic evaluations of substance use disorders. / McCollister, Kathryn; Yang, Xuan; Sayed, Bisma; French, Michael; Leff, Jared A.; Schackman, Bruce R.

In: Journal of Substance Abuse Treatment, Vol. 81, 01.10.2017, p. 25-34.

Research output: Contribution to journalArticle

McCollister, Kathryn ; Yang, Xuan ; Sayed, Bisma ; French, Michael ; Leff, Jared A. ; Schackman, Bruce R. / Monetary conversion factors for economic evaluations of substance use disorders. In: Journal of Substance Abuse Treatment. 2017 ; Vol. 81. pp. 25-34.
@article{a8e62dd65acf4b718cf892878124be31,
title = "Monetary conversion factors for economic evaluations of substance use disorders",
abstract = "Aims Estimating the economic consequences of substance use disorders (SUDs) is important for evaluating existing programs and new interventions. Policy makers in particular must weigh program effectiveness with scalability and sustainability considerations in deciding which programs to fund with limited resources. This study provides a comprehensive list of monetary conversion factors for a broad range of consequences, services, and outcomes, which can be used in economic evaluations of SUD interventions (primarily in the United States), including common co-occurring conditions such as HCV and HIV. Methods Economic measures were selected from standardized clinical assessment instruments that are used in randomized clinical trials and other research studies (e.g., quasi-experimental community-based projects) to evaluate the impact of SUD interventions. National datasets were also reviewed for additional SUD-related consequences, services, and outcomes. Monetary conversion factors were identified through a comprehensive literature review of published articles as well as targeted searches of other sources such as government reports. Results Eight service/consequence/outcome domains were identified containing more than sixty monetizable measures of medical and behavioral health services, laboratory services, SUD treatment, social services, productivity outcomes, disability outcomes, criminal activity and criminal justice services, and infectious diseases consequences. Unit-specific monetary conversion factors are reported, along with upper and lower bound estimates, whenever possible. Conclusions Having an updated and standardized source of monetary conversion factors will facilitate and improve future economic evaluations of interventions targeting SUDs and other risky behaviors. This exercise should be repeated periodically as new sources of data become available to maintain the timeliness, comprehensiveness, and quality of these estimates.",
keywords = "Cost-benefit analysis, Cost-effectiveness analysis, Economic consequences, Economic evaluation, Monetary conversion factors, Substance use disorders",
author = "Kathryn McCollister and Xuan Yang and Bisma Sayed and Michael French and Leff, {Jared A.} and Schackman, {Bruce R.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1016/j.jsat.2017.07.008",
language = "English (US)",
volume = "81",
pages = "25--34",
journal = "Journal of Substance Abuse Treatment",
issn = "0740-5472",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Monetary conversion factors for economic evaluations of substance use disorders

AU - McCollister, Kathryn

AU - Yang, Xuan

AU - Sayed, Bisma

AU - French, Michael

AU - Leff, Jared A.

AU - Schackman, Bruce R.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Aims Estimating the economic consequences of substance use disorders (SUDs) is important for evaluating existing programs and new interventions. Policy makers in particular must weigh program effectiveness with scalability and sustainability considerations in deciding which programs to fund with limited resources. This study provides a comprehensive list of monetary conversion factors for a broad range of consequences, services, and outcomes, which can be used in economic evaluations of SUD interventions (primarily in the United States), including common co-occurring conditions such as HCV and HIV. Methods Economic measures were selected from standardized clinical assessment instruments that are used in randomized clinical trials and other research studies (e.g., quasi-experimental community-based projects) to evaluate the impact of SUD interventions. National datasets were also reviewed for additional SUD-related consequences, services, and outcomes. Monetary conversion factors were identified through a comprehensive literature review of published articles as well as targeted searches of other sources such as government reports. Results Eight service/consequence/outcome domains were identified containing more than sixty monetizable measures of medical and behavioral health services, laboratory services, SUD treatment, social services, productivity outcomes, disability outcomes, criminal activity and criminal justice services, and infectious diseases consequences. Unit-specific monetary conversion factors are reported, along with upper and lower bound estimates, whenever possible. Conclusions Having an updated and standardized source of monetary conversion factors will facilitate and improve future economic evaluations of interventions targeting SUDs and other risky behaviors. This exercise should be repeated periodically as new sources of data become available to maintain the timeliness, comprehensiveness, and quality of these estimates.

AB - Aims Estimating the economic consequences of substance use disorders (SUDs) is important for evaluating existing programs and new interventions. Policy makers in particular must weigh program effectiveness with scalability and sustainability considerations in deciding which programs to fund with limited resources. This study provides a comprehensive list of monetary conversion factors for a broad range of consequences, services, and outcomes, which can be used in economic evaluations of SUD interventions (primarily in the United States), including common co-occurring conditions such as HCV and HIV. Methods Economic measures were selected from standardized clinical assessment instruments that are used in randomized clinical trials and other research studies (e.g., quasi-experimental community-based projects) to evaluate the impact of SUD interventions. National datasets were also reviewed for additional SUD-related consequences, services, and outcomes. Monetary conversion factors were identified through a comprehensive literature review of published articles as well as targeted searches of other sources such as government reports. Results Eight service/consequence/outcome domains were identified containing more than sixty monetizable measures of medical and behavioral health services, laboratory services, SUD treatment, social services, productivity outcomes, disability outcomes, criminal activity and criminal justice services, and infectious diseases consequences. Unit-specific monetary conversion factors are reported, along with upper and lower bound estimates, whenever possible. Conclusions Having an updated and standardized source of monetary conversion factors will facilitate and improve future economic evaluations of interventions targeting SUDs and other risky behaviors. This exercise should be repeated periodically as new sources of data become available to maintain the timeliness, comprehensiveness, and quality of these estimates.

KW - Cost-benefit analysis

KW - Cost-effectiveness analysis

KW - Economic consequences

KW - Economic evaluation

KW - Monetary conversion factors

KW - Substance use disorders

UR - http://www.scopus.com/inward/record.url?scp=85026546847&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026546847&partnerID=8YFLogxK

U2 - 10.1016/j.jsat.2017.07.008

DO - 10.1016/j.jsat.2017.07.008

M3 - Article

C2 - 28847452

AN - SCOPUS:85026546847

VL - 81

SP - 25

EP - 34

JO - Journal of Substance Abuse Treatment

JF - Journal of Substance Abuse Treatment

SN - 0740-5472

ER -